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Esop�ageal cancer is relatively rare� but nevert�e-
less one of t�e deadliest malignancies� wit� five-year 
survival rates not exceeding 1�%. Squamous cell car-
cinoma remains t�e most prevalent type� but adeno-
carcinomas are increasing in number� especially in t�e 
developed countries [1]. Tumor resection remains t�e 
only effective treatment option; �owever� it is associ-
ated wit� �ig� morbidity and mortality rates [�]. In t�is 
respect� t�e accurate identification of �ig�-risk patients 
is of great clinical importance. However� prognostication 
in esop�ageal malignancies continues to be c�alleng-
ing [�]. A number of models for outcome prediction� 
based on various epidemiological� bioc�emical� and 
clinico-pat�ological variables� �as been developed. 
Preoperative systemic inflammation �as frequently been 
recognized as an independent prognosticator of poor 
outcome in esop�ageal malignancies [�]. Recently� 
abnormal results of functional respiratory test �ave also 
been found to be associated wit� postoperative deat� 
in patients undergoing esop�agectomy [4].
A considerable number of esop�ageal cancer 
patients suffers from c�ronic obstructive pulmonary 
disease �COPD�� a condition defined as airflow limita-
tion� w�ic� is not fully reversible. T�e pat�ogeneses 
of bot� COPD and esop�ageal cancer� of squamous 
origin in particular� are closely linked to tobacco smoke 
exposure. It is estimated t�at up to 9�% of patients wit� 
esop�ageal cancers [�] and 9�% of COPD patients 
[6] are current or former smokers. COPD is a clini-
cally significant causative factor of t�e development 
of respiratory insufficiency in patients wit� esop�ageal 
malignancies. In turn� respiratory insufficiency may 
modify t�e course of cancer.
According to t�e current state of knowledge, bot� 
cancer [�] and COPD [�� 9] are considered systemic 
inflammatory diseases. T�e mec�anisms of systemic 
inflammation in COPD are not fully understood. T�ere 
is� �owever� a strong evidence for systemic oxidative 
stress� quantitative and functional c�anges in perip�e-
ral blood proinflammatory cells� and an elevation of 
proinflammatory cytokines [1�].
T�e results of our previous studies s�owed t�at 
t�e coexistence of COPD-related respiratory insuffi-
ciency in patients wit� esop�agogastric malignancies 
is linked wit� more aggressive cancer be�avior. Poor 
systemic oxygenation status �as been associa ted 
wit� locally advanced tumors� in w�ic� t�e key an-
giogenic factor� vascular endot�elial growt� factor A 
�VEGF-A�� seems to participate [11]. COPD-related 
systemic �ypoxemia may also stimulate t�e production 
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of ot�er inflammatory mediators and be responsible 
for nutritional c�anges [1�]. T�erefore� t�e present 
study was designed to test t�e �ypot�esis t�at t�e 
coexistence of COPD-related �ypoxemia may result 
in more pronounced inflammatory response and al-
terations in inflammatory� nutritional� and angiogenic 
indices t�an in normoxemic patients wit� esop�ageal 
cancer alone.
MATERIALS AND METHODS
Patients. T�e study group consisted of �� sub-
jects: �� esop�ageal cancer patients ��6 wit� squa-
mous cell carcinomas of t�e esop�agus and nine wit� 
adenocarcinomas located in t�e lower esop�agus 
and gastric cardia� and 4� �ealt�y individuals �con-
trols�. T�e controls were blood donors �6 females and 
41 males� mean age: 44.� years�� acknowledged to 
be �ealt�y on t�e basis of routine laboratory tests� 
w�ose sera were obtained from t�e Regional Center of 
Blood Donation and T�erapeutics� Wroclaw� Poland. 
T�e cancer patients �� females and �� males� mean 
age: 6� years� were clinically staged according to t�e 
guidelines of t�e UICC TN� [1�] system on t�e basis of 
upper digestive tract �udt� endoscopy wit� biopsy and 
pat�ological examination� contrast radiograp�ic studies 
of t�e udt wit� barium or gastrografin� posteroanterior 
and lateral c�est radiograp�y� ultrasound examination 
of t�e abdominal cavity and cervical nodes� t�orax and 
abdominal cavity CT� and diagnostic laparotomy and 
t�oracotomy. T�ere were seven patients wit� stage 
II� 1� wit� stage III� and 1� wit� stage IV. T�e recruited 
cancer patients �ad long �istories of �eavy smoking. 
Analysis of blood gases was performed as part of t�e 
routine pretreatment assessment of t�e patients’ gen-
eral condition. T�e measurement of oxygenation status 
was conducted on t�e patients at rest breat�ing room 
air. Partial respiratory insufficiency �pO� < 6� mmHg 
wit�out �ypercapnia� was found in 19 of t�e cancer 
patients and was related to t�e co-existence of COPD. 
T�ere were no differences regarding disease stage 
distribution ��1 vs 4�%� p = �.����� t�e presence of re-
gional metastasis �lymp� node metastasis� ��� vs �1%� 
p = �.1���� or distant metastasis ��� vs ��%� p = �.���� 
between t�e groups of cancer patients wit�out and wit� 
systemic �ypoxemia� respectively. However� t�ere was 
a significantly �ig�er incidence of locally advanced 
tumors �T4� in t�e �ypoxemic t�an in t�e normoxemic 
patients ��9 vs �1%� p = �.����. T�e incidence of mild-
grade anemia �n = 19� was similar in bot� groups �6�% 
vs 4�%� p = �.�1��. T�e study protocol was approved 
by t�e �edical Et�ics Committee of Wroclaw �edical 
University� Wroclaw� Poland.
Analytical methods. All examined indices were 
determined in sera obtained from clotted �1� min� RT� 
and centrifuged �1� min� ���� rpm� blood� w�ereby 
t�e time regime was strictly ad�ered to. Hig�-sensitive 
C-reactive protein �CRP� was determined by t�e latex 
particle-en�anced immunoturbidimetric met�od wit� 
t�e CRPex-HS CRP test provided from Good Biotec� 
Corp. �Taiwan�� adjusted to t�e micro-manual proce-
dure. T�e test is based on t�e agglutination of serum 
CRP wit� latex particles sensitized wit� t�e ΔFc fragment 
of duck anti-CRP IgY antibodies increasing sample 
turbidity� measured spectrop�otometrically at ��� nm. 
Albumin levels were determined by t�e bromocresol 
green met�od� based on t�e colorimetric assessment 
�λ = 6�� nm� of t�e albumin-dye complex formed 
at acidic pH. T�e reagents were supplied by Stamar 
�Poland�. Transferrin was assessed by t�e en�anced 
immunoturbidimetric met�od wit� a transferrin assay kit 
provided by Stamar �Poland� according to t�e supplier’s 
protocol adjusted to micro-assay conditions. T�e test is 
based on en�anced reaction between serum transferrin 
and rabbit anti-�uman transferrin antibodies causing 
increased turbidity� measured spectrop�otometrically 
at �9� nm. T�e levels of IL-1� IL-6� IL-�� and TNF-α were 
determined wit� PeliKine Compact �uman cytokine 
ELISA kits supplied by Sanquin �Holland� according 
to t�e manufacturer’s instructions. �idkine concen-
trations were measured wit� a previously described 
double-antibody sandwic� indirect ELISA �DASI-ELISA� 
in w�ic� rabbit �Gentaur� Belgium� and goat �RnD Sys-
tems� USA� anti-�uman midkine polyclonal antibodies 
were employed [14]. PDGF levels �PDGF-BB� were as-
sessed wit� Human PDGF-BB� Stratikine ELISA from 
Strat�mann Biotec GmbH �Germany�. Due to t�e strong 
relation between serum PDGF level and platelet count 
�PLT�� we divided eac� individual PDGF concentration by 
t�e subject’s PLT �t�e corrected PDGF factor — cPDGF 
[pg x 1�-6/PLT]�.
Statistical analysis. T�e D’Agostino-Pearson test 
for normality was applied for data distribution analysis. 
Normally distributed data �CRP� transferrin� albumin� are 
presented as arit�metic means� data distributed nor-
mally after log-transformation �IL-6� IL-�� midkine� and 
cPDGF� as geometric means� and t�e ot�er values �IL-1 
and TNF-α� as medians� all accompanied by 9�% CI. 
T�e significance of differences between groups was 
examined wit� t�e t-test for independent samples or t�e 
�ann — W�itney U test wit� respect to data distribution. 
Correlation analysis was conducted wit� Spearman’s 
or Pearson’s test wit� respect to t�e data type and dis-
tribution. Differences in incidence rates were analyzed 
wit� Fis�er’s exact test. All tests were two-sided and p 
values ≤ �.�� were considered significant. Statistical 
analysis was conducted wit� �edCalc® version 9.�.1.� 
statistical software.
RESULTS
Relationship between COPD-related chronic re-
spiratory insufficiency and the nutritional status of 
esophageal cancer patients. T�e nutritional status of 
cancer patients was evaluated in terms of B�I and sub-
stantial involuntary weig�t loss �≥ �% in a t�ree-mont� 
period�. T�ere was no difference �p = �.444� in t�e inci-
dence of underweig�t subjects among normoxemic and 
�ypoxemic cancer patients. T�ere was� �owever� a clear 
tendency towards diminis�ed pO� levels ��6.1 mmHg 
�9�% CI: ��.��6�.�� vs 6�.� mmHg ���.1�66.��� p = 
�.1�9� and reduced saturation �9�.�% ��6.4�9�.9� vs 
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9�.�% �91.��9�.6�� p = �.1��� in underweig�t cancer 
patients compared wit� t�ose wit� correct weig�t.
Forty percent of normoxemic but 6�% of �ypoxemic 
cancer patients suffered from substantial weig�t loss� 
but t�e difference did not reac� statistical significance 
�p = �.169�. Similarly� t�ere was a trend towards re-
duced pO� in t�e cancer patients experiencing weig�t 
loss compared wit� t�ose w�ose weig�t remained 
unaltered ���.� mmHg ���.��6�.1� vs 6�.4 mmHg 
���.��6�.9�� p = �.1���. T�is trend reac�ed statistical 
significance w�en SaO� instead of pO� was analyzed 
�9�.�% ���.��9�.4� and 9�.�% �91.��94.��� respec-
tively� p = �.��6�.
Relationship between COPD-related chronic re-
spiratory insufficiency and acute-phase response 
proteins (APRP) in esophageal cancer patients. 
T�e levels of transferrin and albumin were significantly 
reduced in cancer patients wit� COPD-related c�ronic 
respiratory insufficiency �Table 1� and positively cor-
related wit� pO� and SaO� levels �Table ��. In turn� t�e 
le vels of CRP were significantly elevated in cancer 
patients wit� respiratory insufficiency �see Table 1� 
and negatively correlated wit� pO� and SaO� levels 
�see Table ��.
Relationship between COPD-related chronic 
respiratory insufficiency and circulating proinflam-
matory and proangiogenic cytokines. T�e levels of 
circulating IL-6 and midkine were elevated in cancer 
patients wit� respiratory insufficiency� t�e concentra-
tions of IL-� and TNF-α did not differ� w�ile cPDGF was 
significantly decreased and IL-1 ex�ibited a similar 
tendency �see Table 1�. 
IL-6 and midkine negatively correlated wit� pO� and 
SaO�� w�ile cPDGF and IL-1 eit�er correlated positively 
or ex�ibited suc� a tendency. No correlation between 
t�e indices of systemic oxygenation status and t�e levels 
of circulating IL-� and TNF-α was found �see Table ��. 
However� in t�e subgroup of cancer patients wit� c�ronic 
respiratory insufficiency� significant negative correlations 
between IL-� and pO� �r = ��.��� p = �.�1�� as well as 
SaO� �r = ��.��� p = �.�1�� were demonstrated. T�ere 
was also a tendency towards a positive relations�ip be-
tween IL-1 and SaO� �r = �.46� p = �.����.
Relationship between the extent of the primary 
tumor (disease T stage), acute-phase proteins, 
and proinflammatory and proangiogenic cyto-
kines. T�ere was a direct correlation between pO� 
�r = ��.49� p = �.��4� or SaO� �r = ��.��� p = �.���� 
levels and tumor T stage in t�e esop�ageal cancer 
patients. Circulating CRP� IL-6� and midkine concen-
trations increased along wit� increasing tumor extent� 
w�ile t�e levels of albumin and transferrin tended 
to decrease. T�e extent of t�e primary tumor �ad 
no impact on IL-1� IL-�� TNF-α� or cPDGF levels in 
t�e examined co�ort of esop�ageal cancer patients 
�Table ��.
Table 2. The relationship between the indices of oxygenation status and 
serum levels of acute phase proteins, proinflammatory and proangiogenic 
cytokines in esophageal cancer patients
Correlation with indices of oxygen status
pO2 SaO2
CRP r = –0.37, p = 0.064 r = –0.40, p = 0.042*
Albumin r = 0.48, p = 0.012* r = 0.53, p = 0.006*
Transferrin r = 0.47, p = 0.016* r = 0.52, p = 0.006
IL-1 r = 0.27, p = 0.145 r = 0.34, p = 0.078
IL-6 r = –0.44, p = 0.016* r = –0.54, p = 0.003*
IL-8 r = –0.02, p = 0.924 r = –0.24, p = 0.179
TNF-α r = –0.04, p = 0.828 r = –0.02, p = 0.905
Midkine r = –0.42, p = 0.011* r = –0.57, p < 0.001*
cPDGF r = 0.53, p = 0.003* r = 0.44, p = 0.020*
*Statistically significant.
Table 3. The relationship between the extent of primary tumor (disease 
T stage) and serum levels of acute phase proteins and proinflammatory 
and proangiogenic cytokines in esophageal cancer patients
Correlation with tumor T stage
CRP r = 0.67, p < 0.001*
Albumin r = –0.33, p = 0.099
Transferrin r = –0.37, p = 0.066
IL-1 r = 0.14, p = 0.468
IL-6 r = 0.75, p < 0.001*
IL-8 r = 0.26, p = 0.139
TNF-α r = –0.03, p = 0.863
Midkine r = 0.45, p = 0.008*
cPDGF r = –0.19, p = 0.322
*Statistically significant.
Relationship between IL-6 levels and other 
variables. Acute-p�ase proteins �ig�ly correlated wit� 
IL-6 levels. T�ere was a substantial correlation wit� IL-� 
and a moderate correlation wit� midkine �Table 4�.
Table 4. The relationship between circulating IL-6 and serum levels of 
acute phase proteins and proinflammatory and proangiogenic cytokines in 
esophageal cancer patients
Correlation with circulating IL-6
CRP r = 0.73, p < 0.0001*
Albumin r = –0.60, p = 0.001*
Transferrin r = –0.77, p < 0.0001*
IL-1 r = –0.02, p = 0.901
IL-8 r = 0.56, p = 0.002*
TNF-α r = –0.02, p = 0.932
Midkine r= 0.38, p = 0.042*
cPDGF r = –0.03, p = 0.894
*Statistically significant.
Relationship between COPD-related chronic 
respiratory insufficiency and circulating proin-
flammatory cells. T�ere was a significant increase 
in t�e number of circulating w�ite blood cells in t�e 
cancer patients wit� systemic �ypoxemia� an effect of 
t�e elevation of neutrop�ils� but not lymp�ocytes. T�e 
Table 1. Alterations in the concentrations of acute-phase proteins and proinflammatory and proangiogenic cytokines in esophageal cancer patients with 
respect to their oxygenation status
Healthy controls (C) Esophageal cancer patients p values for pair-wise comparisonsNormoxemic (N) Hypoxemic (H) C vs N C vs H N vs H
CRP [mg/l] 6.8 (0.6–13.1) 54.7 (14.7–95.0) 129.9 (97.3–162.5) 0.024* < 0.0001* 0.004*
Albumin [g/l] 39.4 (36.7–42.0) 37.1 (34.9–39.2) 31.9 (29.4–34.4) 0.173 0.0001* 0.002*
Transferrin [mg/dl] 293 (276–309) 316 (291–342) 234 (184–284) 0.104 0.028* 0.005*
IL-1 [pg/ml] 0.79 (0–2.10) 3.18 (1.96–4.73) 2.58 (1.63–3.87) 0.002* 0.006* 0.254
IL-6 [pg/ml] 0.70 (0.56–0.87) 2.21 (1.13–4.33) 9.97 (4.58–21.74) 0.003* < 0.0001* 0.005*
IL-8 [pg/ml] 9.68 (7.99–11.74) 33.7 (19.5–58.5) 32.8 (19.6–54.9) < 0.001* 0.0001* 0.936
TNF-α [pg/ml] 0.66 (0.33–1.59) 0.89 (0–3.91) 1.02 (0.44–1.99) 0.449 0.275 0.913
Midkine [pg/ml] 25 (10–63) 944 (669–1331) 2101 (1542–2861) < 0.0001* < 0.0001* < 0.001*
cPDGF pgx10-6/PLT 22.5 (19.2–26.3) 17.3 (14.0–21.3) 12.2 (10.0–14.8) 0.055 < 0.0001* 0.014*
*Statistically significant.
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increase in platelet count was not found to be signifi-
cant �Table ��. A significant correlation was observed 
only between leukocyte count and bot� pO� �r = ��.��� 
p = �.�4�� and SaO� �r = ��.4�� p = �.����.
Table 5. Alterations in the counts of proinflammatory cells in esophageal 
cancer patients in response to systemic hypoxemia
Esophageal cancer patients p valueNormoxemic Hypoxemic
Leukocyte count [× 103/μl] 8.37 (6.85–9.90) 11.77 (9.80–13.74) 0.009*
Neutrophil count [× 103/μl] 6.09 (4.52–7.65) 9.10 (6.92–11.28) 0.025*
Lymphocyte count [× 103/μl] 1.70 (1.25–2.15) 1.81 (1.45–2.16) 0.700
Platelet count [× 103/μl] 292 (214–370) 322 (279–365) 0.480
*Statistically significant.
Of all t�e studied indices� t�e acute-p�ase proteins 
albumin �r = ��.4�� p = �.����� transferrin �r = ��.41� 
p = �.���� and CRP �r = �.��� p < �.���1� as well as 
IL-6 �r = �.6�� p < �.��1� and midkine �r = �.�6� p = 
�.���� correlated wit� leukocyte count. Similarly� only 
albumin �r = ��.46� p = �.����� transferrin �r = ��.46� 
p = �.��6�� CRP �r = �.��� p < �.���1�� and IL-6 �r = 
�.6�� p < �.��1� correlated wit� neutrop�il count. No 
significant correlation wit� lymp�ocyte count was 
observed� w�ile only CRP �r = �.44� p = �.��6� and 
midkine �r = �.��� p = �.���� correlated wit� platelet 
count and IL-6 tended to ex�ibit a similar trend �r = 
�.��� p = �.�6��.
DISCUSSION
Progressive worsening of a patient’s nutritional 
status and loss of body weig�t leading to t�e deve-
lopment of cac�exia is a common consequence of 
esop�ageal cancer [1�] and COPD [6� 1�]. Unintended 
weig�t loss is observed in about ��% of COPD patients 
wit� c�ronic respiratory failure [1�] and in about ��% 
of newly diagnosed esop�ageal cancer patients [16]. 
Tissue �ypoxia� an effect of systemic �ypoxemia� �as 
been implicated in increasing t�e metabolic rate [1�]. 
We t�erefore investigated� w�et�er t�e presence of 
COPD-related respiratory insufficiency was associa-
ted wit� a �ig�er prevalence of under-nutrition in 
patients wit� esop�ageal malignancies. However� we 
failed to demonstrate suc� an association in t�e cur-
rent co�ort of patients. B�I �as been criticized as an 
inadequate index of cancer cac�exia since it excludes 
t�ose cancer patients w�o ex�ibit normal B�I alt�oug� 
t�ey expe rience substantial weig�t loss [1�� 1�]. Ac-
cordingly� t�e measurement of oxygenation status 
revealed a clear tendency towards decreased oxygen 
partial pressure and saturation in cancer patients wit� 
COPD-related respiratory insufficiency. T�e presence 
of accelerated and involuntary weig�t loss is consid-
ered a stronger indicator of cancer cac�exia [1�]. 
Indeed� t�e diffe rences obtained wit� t�is index were 
more significant. T�e lack of statistical significance 
may result from t�e relatively low number of analyzed 
cases� inadequate to demonstrate differences in t�e 
incidence of weig�t loss. T�e prevalence of weig�t 
loss in esop�agogastric cancer is �ig�� reac�ing ��% 
of newly diagnosed cases [1�]. On t�e ot�er �and� 
esop�ageal cancer is rare [1] and COPD affects only 
1�% of smokers [6]� resulting in a limited number of 
patients available for t�e current study. 
Supporting t�e t�esis of a worsening of nutritional 
status of cancer patients by systemic �ypoxemia� 
we found a significant decrease in t�e levels of nutri-
tional markers� transferrin and albumin� in patients wit� 
COPD-related respiratory insufficiency. �oreover� t�e 
concentrations of bot� markers positively correlated 
wit� pO� and SaO� levels. T�e association between 
systemic �ypoxemia and cac�exia was furt�er sup-
ported by t�e elevation in IL-6 levels� a procac�ectic 
cytokine found to be elevated in esop�agogastric 
cancer patients wit� substantial weig�t loss [1�]� and 
its negative correlation wit� pO� and SaO�. T�ere was 
no difference in t�e levels of t�e ot�er two key pro-
cac�ectic cytokines TNF-α and IL-1. However� t�eir 
up-regulation seems to be time limited and to �ave 
only a local range� w�ile systemic elevation �as been 
rarely detected [19].
Tumor tissue �ypoxia �as been linked wit� ampli-
fied aggressiveness of neoplasms [��]� but t�e effect 
of systemic �ypoxemia �as not been extensively stu-
died. We previously linked systemic �ypoxemia wit� 
a �ig�er extent of primary tumor and elevated angio-
genic potential� manifested by a significant increase 
in circulating VEGF-A [11]. T�e negative impact on 
nutritional status reported in t�e present study furt�er 
contributes to t�e adverse effects of systemic �ypo-
xemia in esop�ageal cancer patients. 
In addition to t�e previously reported VEGF-A 
elevation [11]� �ere we revealed a systemic �ypo-
xemia-related increase in t�e concentration of mid-
kine� anot�er mediator of angiogenesis [�1]. We also 
confirmed midkine’s relations�ip to disease T stage� 
as demonstrated earlier [��]. �idkine’s elevation in 
response to �ypoxia t�us provides furt�er evidence for 
t�e existence of a link between systemic �ypoxemia 
and greater cancer aggressiveness� mediated by an-
giogenic factors. Similarly to VEGF-A [��]� midkine �as 
previously been s�own to be up-regulated by �ypoxia-
inducible factor 1α �HIF-1α� [��]� a key redox-sensitive 
transcription factor [��]. �oreover� t�e binding sites 
for nuclear factor κB �NFκB� and activator protein-1 
�AP-1�� ot�er oxygen-dependent transcription factors 
[��]� �ave been demonstrated in t�e midkine promoter 
sequence as well [�4]. However� midkine oversecretion 
in response to systemic �ypoxemia �as not been re-
ported so far. �idkine elevation may reflect t�e ongo-
ing process of repair and restructuring of t�e airways in 
t�e course of COPD [��]� since midkine’s involvement 
in lung remodeling �as been previously reported [��]. 
Interestingly� we s�owed IL-� elevation in response to 
a tumor-bearing state� but no furt�er rise in �ypoxemic 
patients� alt�oug� a gene of t�is proinflammatory and 
proangiogenic cytokine is transactivated by NFκB [��]. 
Nevert�eless� IL-� level increased along wit� worsen-
ing of patients’ oxygenation status� but t�e impact of 
systemic �ypoxemia was demonstrated exclusively in 
patients wit� respiratory insufficiency. 
Surprisingly� some pro-angiogenic cytokines 
appear to be inversely regulated. We observed a 
decrease in cPDGF-BB levels in cancer patients wit� 
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COPD-related respiratory insufficiency� despite t�e 
fact t�at PDGF gene �as bot� a �ypoxia-responsive 
element �HRE� sequence as well as a binding site for 
AP-1 [��]. �oreover� PDGF �as been implicated in t�e 
remodeling of t�e airway wall in t�e course of COPD 
[�6]. We �ave no explanation for t�is p�enomenon� but 
it seems to indeed be related to t�e factor’s diminis�ed 
secretion� since platelet count was not significantly 
altered. �oreover� despite t�e lack of differences in 
mean levels� IL-1 also appears to be negatively af-
fected by t�e decrease in blood oxygenation. 
T�e depletion of albumin and transferrin levels may 
contribute to en�anced oxidative stress and inflam-
matory response in cancer patients wit� COPD. Cor-
respondingly� we demonstrated an elevation in CRP� 
inversely correlating wit� systemic oxygenation status. 
CRP elevation �as been found to be an independent 
prognostic factor in esop�ageal cancer [�]. Up-regu-
lation of CRP secretion �as also been demonstrated 
in COPD� being more pronounced during disease 
exacerbation [1�]. Our study s�ows furt�er CRP ele-
vation in cancer patients wit� coexisting respiratory 
insufficiency related to COPD. However� t�e impact of 
systemic �ypoxemia on CRP concentration� similarly 
to transferrin and albumin� mig�t be mediated by IL-6� 
a well-known modulator of t�e acute-p�ase response 
[��]. Indeed� t�e levels of acute-p�ase proteins more 
strongly correlated wit� IL-6 t�an wit� pO� and SaO� 
levels. Interestingly� CRP elevation markedly reflected 
t�e increase in t�e extent of primary tumor� suggesting 
t�at tumor cells mig�t participate in CRP secretion. 
T�is is in agreement wit� t�e results of immuno�isto-
c�emical studies by Nozoe et al. [��] demonstrating 
CRP expression in esop�ageal squamous cell carci-
noma cancer tissues.
In line wit� CRP elevation� we also observed a sig-
nificant increase in leukocyte and neutrop�il counts� 
moderately related to pO� and SaO� levels. T�is obser-
vation is consistent wit� t�e current knowledge on t�e 
involvement of perip�eral neutrop�ils in t�e systemic 
effects of COPD [1�]. A substantial increase in t�e 
number of inflammatory cells as well as en�anced cell 
activation �ave been linked to t�e presence of elevated 
levels of circulating c�emoattractants [�9]. �idkine� 
demonstrated �ere to be oversecreted in cancer 
patients wit� systemic COPD-related �ypoxemia� is a 
potent neutrop�il and macrop�age c�emoattractant 
[��]. Correspondingly� midkine levels correlated wit� 
w�ite blood cell counts in t�e examined co�ort of 
cancer patients.
We �ypot�esized t�at COPD-related respiratory 
insufficiency in patients wit� esop�ageal malignancies 
may be associated wit� more pronounced inflamma-
tion� under-nutrition� and angiogenesis. Generally� our 
results seem to confirm t�is �ypot�esis. Taking into ac-
count t�e impact t�ese factors �ave on pro gnosis� we 
believe t�at our results may contribute not only to a better 
understanding of t�e effect systemic �ypoxemia exerts 
on t�e course of cancer disease� but may �elp in better 
management of esop�ageal cancer patients as well.
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COPD-ЗАВИСИМАЯ РЕСПИРАТОРНАЯ НЕДОСТАТОЧНОСТЬ 
УСИЛИВАЕТ СИСТЕМНОЕ ВОСПАЛЕНИЕ, ИСТОЩЕНИЕ 
И АНГИОГЕНЕЗ ПРИ ЗЛОКАЧЕСТВЕННЫХ 
ОПУХОЛЯХ ПИЩЕВОДА
Многие больные раком пищевода страдают от респираторной недостаточности из-за развития хронического обструк-
тивного легочного заболевания (COPD). Цель: Проверить гипотезу о возможной связи системной гипоксемии, ассоци-
ированной с COPD, с усилением воспалительных процессов, истощением и ангиогенезом у больных раком пищевода. 
Методы: у 35 больных раком пищевода и 42 здоровых доноров определяли уровень CRP, альбумина, трансферина, 
интерлейкина-1, интерлейкина-6, интерлейкина-8, TNF-α, PDGF-BB и мидкина в сыворотке крови, показатели BMI и 
потери веса больных, а также показатели уровня оксигенации крови (pO2, SaO2). Результаты: частота возникновения 
кахексии была выше у больных с системной гипоксемией (67 против 40%, p = 0,169). Средний уровень SaO2 был также 
значительно снижен у больных с кахексией (90,3 против 93,3%, p = 0,026), с той же тенденцией и для уровня pO2 (58,0 
против 63,4 mmHg, p = 0,120). Концентрации трансферина (234 против 316 мг/дл, p = 0,005) и альбумина (31,9 против 
37,1 мг/дл, p = 0,002) были снижены, CRP повышен (129,9 против 54,7 мг/л, p = 0,004) у гипоксемических пациентов, 
что кореллировало с показателями pO2 (r = 0,47, p = 0,016; r = 0,48, p = 0,012; r = –0,37, p = 0,064) и SaO2 (r = 0,52, 
p = 0,006; r = 0,53, p = 0,006; r = –0,40, p = 0,042). Уровень интерлейкина-6 (9,97 против 2,21 pg/ml, p = 0,005) и мидкина 
(2101 против 944 pg/ml, p < 0,001) был также повышен, а уровень PDGF-BB понижен (12,2 против 17,3 pg × 10-6/PLT, 
p = 0,014) у гипоксемических больных по сравнению с показателями при нормоксемии. Уровни интерлейкина-6 и мидкина 
негативно кореллировали с показателями pO2 (r = –0,44, p = 0,016; r = –0,42, p = 0,011) и SaO2 (r = –0,54, p = 0,003; 
r = –0,57, p < 0,0001) и позитивно — с PDGF-BB (r = 0,53, p = 0,003; r = 0,44, p = 0,020). На уровень интерлейкина-8 
влияли pO2 (r = –0,55, p = 0,015) и SaO2 (r = –0,55, p = 0,018) только у больных с гипоксемией. Выводы: ассоциированная 
с COPD системная гипоксемия негативно влияет на состояние больных раком пищевода за счет ускорения воспалительных 
процессов, истощения и ангиогенеза.
Ключевые слова: рак пищевода, COPD, гипоксемия, воспаление, цитокины.
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